Impact of inappropriate empirical antibiotic treatment on clinical outcomes of urinary tract infections caused by Escherichia coli: a retrospective cohort study

被引:14
|
作者
Zhu, Hongying [1 ]
Chen, Yanhui [1 ]
Hang, Yaping [1 ]
Luo, Hong [1 ]
Fang, Xueyao [1 ]
Xiao, Yanping [1 ]
Cao, Xingwei [1 ]
Zou, Shan [1 ]
Hu, Xiaoyan [1 ]
Hu, Longhua [1 ]
Zhong, Qiaoshi [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Jiangxi Prov Key Lab Med, Clin Lab, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Inappropriate empirical antibiotic treatment; Urinary tract infection; Escherichia coli; Fluoroquinolones; CIPROFLOXACIN; GUIDELINES; THERAPY;
D O I
10.1016/j.jgar.2021.05.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to determine the clinical impact of inappropriate empirical antibiotic treatment (IEAT) compared with appropriate empirical antibiotic treatment (AEAT) in hospitalised patients with urinary tract infections (UTIs) caused by Escherichia coli (E. coli). Methods: This retrospective cohort study included adult patients with a primary diagnosis of UTI who were treated with empirical antibiotics at a tertiary hospital in southern China over a 2-year period. Clinical data of patients who received IEAT were compared with those of patients receiving AEAT. We used multivariable logistic regression to identify the predictors for receiving IEAT and the risk factors affecting clinical outcomes. Results: A total of 213 patients were enrolled (median age, 61 years), of whom 103 (48.4%) received IEAT. IEAT was associated with empirical use of fluoroquinolones, male sex and age-adjusted Charlson comorbidity index (aCCI) score > 6. Hospital length of stay (LOS) was longer for patients who received IEAT than for those who received AEAT (13.6 +/- 8.6 days vs. 10.8 +/- 7.9 days; P = 0.008). IEAT was an independent risk factor for longer LOS along with aCCI score >= 2, lung disease and cardiac disease. Conclusion: Empirical use of fluoroquinolones for UTIs should be avoided, especially in male patients with aCCI score > 6. Improved empirical antimicrobial therapy may have a beneficial impact in reducing bacterial resistance and healthcare costs by decreasing the LOS. Therefore, interventions to promote indepth antibiotic stewardship programmes in China are needed. (C) 2021 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
  • [41] Recurrent Urinary Tract Infections Caused by Multidrug-resistant Uropathogenic Escherichia coli: Implications for Diagnosis and Treatment
    Liu, Shiwei
    Zhang, Ning
    Chen, Zeliang
    EUROPEAN UROLOGY, 2013, 63 (02) : 410 - 411
  • [42] COMPARISON OF AMPICILLIN AND NALIDIXIC-ACID IN TREATMENT OF URINARY-TRACT INFECTIONS CAUSED BY ESCHERICHIA-COLI
    TOIVONEN, S
    PENTIKAINEN, P
    LEIRISALO, M
    PYORALA, K
    ACTA MEDICA SCANDINAVICA, 1974, 195 (03): : 181 - 184
  • [43] Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study
    Edwards, B. D.
    Somayaji, R.
    Greysson-Wong, J.
    Izydorczyk, C.
    Waddell, B.
    Storey, D. G.
    Rabin, H. R.
    Surette, M. G.
    Parkins, M. D.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (01):
  • [44] Escherichia coli bacteremic urinary tract infections -: Clinical aspects and pronostic factors
    Vandenbos, F
    Ozanne, A
    Burel-Vandenbos, F
    Tempesta, S
    Fosse, T
    Dellamonica, P
    PRESSE MEDICALE, 2004, 33 (13): : 847 - 851
  • [45] Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data
    Alós, JI
    Serrano, MG
    Gómez-Garcés, JL
    Perianes, J
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (03) : 199 - 203
  • [46] Bacterial Flora and Treatment Strategies in Women With Escherichia coli Urinary Tract Infections
    Mahesh, Saisri
    Carmelin, Durai Singh
    Muthusamy, Raman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [47] Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli
    Balague, Claudia
    Sturtz, Nelson
    Rey, Rosario
    De Ruiz, Clara Silva
    Nader-Macias, Maria Elena
    Duffard, Ricardo
    De Duffard, Ana Maria Evangelista
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2006, 48 (03): : 337 - 346
  • [48] AZTREONAM IN THE TREATMENT OF URINARY-TRACT E-COLI-CAUSED INFECTIONS
    ABOULENEIN, HY
    SAUDI MEDICAL JOURNAL, 1990, 11 (05) : 418 - 419
  • [49] Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study
    Jansaker, Filip
    Boel, Jonas Bredtoft
    Thonnings, Sara
    Hertz, Frederik Boetius
    Hansen, Katrine Hartung
    Frimodt-Moller, Niels
    Knudsen, Jenny Dahl
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 1691 - 1702
  • [50] Characterization of antibiotic-resistant Escherichia coli associated with urinary tract infections in Southern Colombia
    Guerrero-Ceballos, Deisy Lorena
    Burbano-Rosero, Edith Mariela
    Mondragon, Eduardo Ibargueen
    UNIVERSITAS SCIENTIARUM, 2020, 25 (03) : 463 - 488